← Open Payments lookup

GENNADIY GOLDVEKHT: Open Payments

NPI 1093212086 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,886 in 90 payments from 12 companies in 2025. Trend: 2023 $1,240 · 2024 $2,048 · 2025 $2,886

Food & beverage: $2,884Education: $2
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.23$964
Lundbeck LLC16$431
Alkermes, Inc.8$306
Axsome Therapeutics, Inc.6$264
Vanda Pharmaceuticals Inc.11$231
Takeda Pharmaceuticals U.S.A., Inc.9$201
Neurocrine BioSciences, Inc.5$145
E.R. Squibb & Sons, L.L.C.3$107
ABBVIE INC.3$78
Teva Pharmaceuticals USA, Inc.3$74

Products named: REXULTI, LYBALVI, Auvelity, FANAPT, TRINTELLIX, INGREZZA, ABILIFY ASIMTUFII, COBENFY.

Industry payments across NY — which companies pay providers there.